One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play – make up the three biotech stocks highlighted in today’s article as having the potential to be major winners in the coming years. For these three biotech stocks investors may want to consider if they have cash they want to deploy in the market, CLICK HERE.